ATRC - AtriCure, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
22.90
-0.17 (-0.74%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close23.07
Open23.07
Bid0.00 x 0
Ask0.00 x 0
Day's Range22.77 - 23.08
52 Week Range14.78 - 25.18
Volume111,133
Avg. Volume198,903
Market Cap786.25M
Beta0.22
PE Ratio (TTM)-22.54
EPS (TTM)-1.02
Earnings DateNov 1, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.63
Trade prices are not sourced from all markets
  • Business Wire9 days ago

    Mike Hooven, Founder of AtriCure (NASDAQ: ATRC) and Enable Injections, Joins Genetesis Board of Directors

    Genetesis, a medical technology company that gives doctors an accurate, non-invasive tool for seeing how the heart beats, announces the addition of Mike Hooven to its Board of Directors.

  • Business Wire10 days ago

    AtriCure to Announce Third Quarter 2017 Financial Results

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced that it will release its third quarter 2017 financial results on Wednesday, November 1, 2017.

  • AtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : September 28, 2017
    Capital Cube22 days ago

    AtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : September 28, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for AtriCure, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Business Wirelast month

    AtriCure Announces U.S. Launch of the AtriClip® PRO•V™ Device

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced that it has launched the AtriClip PRO•V™ Left Atrial Appendage Exclusion System in the United States.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of ATRC earnings conference call or presentation 27-Jul-17 8:30pm GMT

    Q2 2017 AtriCure Inc Earnings Call

  • Business Wire2 months ago

    AtriCure to Present at the Morgan Stanley Global Healthcare Conference

    AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York on Tuesday, September 12, 2017.

  • Capital Cube2 months ago

    ETFs with exposure to AtriCure, Inc. : August 15, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AtriCure, Inc. Here are 5 ETFs with the largest exposure to ATRC-US. Comparing the performance and risk of AtriCure, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • AtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : August 15, 2017
    Capital Cube2 months ago

    AtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : August 15, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for AtriCure, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • AtriCure, Inc. :ATRC-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017
    Capital Cube3 months ago

    AtriCure, Inc. :ATRC-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017

    Categories: Yahoo FinanceGet free summary analysis AtriCure, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of AtriCure, Inc. – Edwards Lifesciences Corporation, Boston Scientific Corporation, ABIOMED, Inc. and Johnson & Johnson (EW-US, BSX-US, ABMD-US and JNJ-US) that have also reported for this period. Highlights Summary ... Read more (Read more...)

  • AtriCure, Inc. breached its 50 day moving average in a Bearish Manner : ATRC-US : July 28, 2017
    Capital Cube3 months ago

    AtriCure, Inc. breached its 50 day moving average in a Bearish Manner : ATRC-US : July 28, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for AtriCure, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Associated Press3 months ago

    AtriCure reports 2Q loss

    On a per-share basis, the Mason, Ohio-based company said it had a loss of 21 cents. The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...

  • Business Wire3 months ago

    AtriCure Reports Second Quarter 2017 Financial Results

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced second quarter 2017 financial results.

  • ACCESSWIRE3 months ago

    Investor Network: AtriCure, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 27, 2017 / AtriCure, Inc. (NASDAQ: ATRC) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, July 27, 2017 at 4:30 PM Eastern Time. ...

  • Business Wire3 months ago

    AtriCure to Present at the Canaccord Genuity 37th Annual Growth Conference

    AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the Canaccord Genuity 37th Annual Growth Conference at the Intercontinental Hotel in Boston on Thursday, August 10, 2017.

  • Business Wire3 months ago

    AtriCure Announces Hiring of Chief Technology Officer

    AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced it has hired Salvatore Privitera as its Chief Technology Officer.

  • Capital Cube3 months ago

    ETFs with exposure to AtriCure, Inc. : July 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AtriCure, Inc. Here are 5 ETFs with the largest exposure to ATRC-US. Comparing the performance and risk of AtriCure, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Business Wire3 months ago

    AtriCure to Announce Second Quarter 2017 Financial Results

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced that it will release its second quarter 2017 financial results on Thursday, July 27, 2017.

  • Business Wire5 months ago

    AtriCure to Present at the JMP Securities Life Science Conference

    AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced that it will present at the JMP Securities Life Science Conference at the St.

  • Capital Cube5 months ago

    ETFs with exposure to AtriCure, Inc. : May 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AtriCure, Inc. Here are 5 ETFs with the largest exposure to ATRC-US. Comparing the performance and risk of AtriCure, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of ATRC earnings conference call or presentation 4-May-17 8:30pm GMT

    Q1 2017 AtriCure Inc Earnings Call

  • AtriCure, Inc. :ATRC-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
    Capital Cube5 months ago

    AtriCure, Inc. :ATRC-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis AtriCure, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of AtriCure, Inc. – Teleflex Incorporated, Edwards Lifesciences Corporation, Boston Scientific Corporation, ABIOMED, Inc., Dextera Surgical, Inc., Johnson & Johnson and Stereotaxis, Inc. (TFX-US, EW-US, BSX-US, ABMD-US, DXTR-US, JNJ-US and ... Read more (Read more...)

  • Here's Why ArtiCure, Inc. Is Up Double-Digits Today
    Motley Fool6 months ago

    Here's Why ArtiCure, Inc. Is Up Double-Digits Today

    Better-than-expected first-quarter results caused ArtiCure's stock to jump.

  • Associated Press6 months ago

    AtriCure reports 1Q loss

    On a per-share basis, the Mason, Ohio-based company said it had a loss of 32 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...

  • Business Wire6 months ago

    AtriCure Reports First Quarter 2017 Financial Results

    AtriCure, Inc. , a leading innovator in treatments for atrial fibrillation and left atrial appendage management, today announced first quarter 2017 financial results.